000 | 02917ngm a2200625 a 4500 | ||
---|---|---|---|
001 | HST4279 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 160825s2016 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a4279 _bHenry Stewart Talks |
035 | _a(UkLoHST)3320 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aSim, Edith, _u(Department of Pharmacology, University of Oxford, UK) _4spk |
|
245 | 1 | 0 |
_aArylamine N-acetyltransferases _h[electronic resource] : _bpart 3 of 3 / _cEdith Sim. |
246 | 3 | _aArylamine N-acetyltransferases 3 | |
260 |
_aLondon : _bHenry Stewart Talks, _c2016. |
||
300 |
_a1 online resource (1 streaming video file (19 min.) : _bcolor, sound). |
||
490 | 1 |
_aDrug metabolizing enzymes : fundamentals, study methods, recent advances and clinical significance, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
500 | _aUpdated version of a talk first published in 2007. | ||
505 | 0 | _aContents: Mechanism of action -- Reaction substrates -- Isoform substrate profiles -- Isoenzymes NAT1 and NAT2 -- Regulation of gene expression -- Pharmacogenetics -- Phenotype/genotype correlation -- Ethnic variation -- Transgenic mouse models -- NAT protein structures -- NAT as a biomarker in breast cancer -- NAT inhibitors as diagnostic agents -- NAT in mycobacteria -- NAT inhibitors as an approach to potential anti-tubercular agents. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 | _aAntibacterial agents. | |
650 | 0 | _aBiochemical markers. | |
650 | 0 |
_aBreast _xCancer. |
|
650 | 0 | _aDrug development. | |
650 | 0 |
_aDrugs _xMetabolism. |
|
650 | 0 | _aEnzyme Inhibitors. | |
650 | 0 | _aIsoenzymes. | |
650 | 0 | _aTransferases. | |
650 | 2 | _aAntitubercular Agents. | |
650 | 2 |
_aArylamine N-Acetyltransferase _xantagonists & inhibitors. |
|
650 | 2 |
_aArylamine N-Acetyltransferase _xgenetics. |
|
650 | 2 |
_aArylamine N-Acetyltransferase _xmetabolism. |
|
650 | 2 |
_aBacterial Infections _xdrug therapy. |
|
650 | 2 | _aBiomarkers. | |
650 | 2 |
_aBreast Neoplasms _xdiagnosis. |
|
650 | 2 |
_aDrug Discovery _xmethods. |
|
650 | 2 |
_aEnzyme Inhibitors _xpharmacology. |
|
650 | 2 | _aEthnic Groups. | |
650 | 2 | _aGene Expression Regulation, Enzymologic. | |
650 | 2 | _aGenetic Association Studies. | |
650 | 2 |
_aIsoenzymes _xmetabolism. |
|
650 | 2 | _aMice, Transgenic. | |
650 | 2 |
_aMycobacterium _xdrug effects. |
|
650 | 2 |
_aPharmaceutical Preparations _xmetabolism. |
|
650 | 2 | _aPharmacogenetics. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pDrug metabolizing enzymes : fundamentals, study methods, recent advances and clinical significance. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/3320/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/16/ _3Series |
999 |
_c76658 _d76658 |